Results 261 to 270 of about 2,938,349 (358)

NMR spectroscopy in drug design [PDF]

, 2001
Markus Heller, Horst Kessler
openalex   +1 more source

TargetSA: adaptive simulated annealing for target-specific drug design. [PDF]

Bioinformatics
Xue Z, Sun C, Zheng W, Lv J, Liu X.
europepmc   +1 more source

RETRACTED: Crystal structure of dengue virus NS3 protease in complex with a bowman-birk inhibitor: implications for flaviviral polyprotein processing and drug design

, 2000
H. M. Krishna Murthy, K. Judge, L.J. DeLucas, Radhakrishnan Padmanabhan   +3 more
openalex   +1 more source

A new molecular simulation software package – Peking University Drug Design System (PKUDDS) for structure-based drug design [PDF]

, 2001
Tingjun Hou, Xiaojie Xu
openalex   +1 more source

Diffusion Models in De Novo Drug Design. [PDF]

J Chem Inf Model
Alakhdar A, Poczos B, Washburn N.
europepmc   +1 more source

Plant Defense Peptides: Exploring the Structure-Function Correlation for Potential Applications in Drug Design and Therapeutics. [PDF]

ACS Omega
Shirsat H, Datt M, Kale A, Mishra M.
europepmc   +1 more source

Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy [PDF]

, 2001
George S. Stergiou
openalex   +1 more source

Accessing Promising Passerini Adducts in Anticancer Drug Design. [PDF]

Molecules
Janeiro AM, González-Bakker A, Padrón JM, Marques CS.   +3 more
europepmc   +1 more source

Mimicking dominant negative inhibition of prion replication through structure-based drug design

, 2000
Véronique Perrier, Andrew C. Wallace, Kiyotoshi Kaneko, Jiri Safar, Stanley B. Prusiner, Fred E. Cohen   +5 more
openalex   +1 more source

Drug Design—Chemistry and Biology [PDF]

, 2001
Tomi K. Sawyer
openalex   +1 more source